These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15713620)

  • 41. Activated G alpha q inhibits p110 alpha phosphatidylinositol 3-kinase and Akt.
    Ballou LM; Lin HY; Fan G; Jiang YP; Lin RZ
    J Biol Chem; 2003 Jun; 278(26):23472-9. PubMed ID: 12704201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Muscle-specific Pikfyve gene disruption causes glucose intolerance, insulin resistance, adiposity, and hyperinsulinemia but not muscle fiber-type switching.
    Ikonomov OC; Sbrissa D; Delvecchio K; Feng HZ; Cartee GD; Jin JP; Shisheva A
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(1):E119-31. PubMed ID: 23673157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy.
    Luo J; McMullen JR; Sobkiw CL; Zhang L; Dorfman AL; Sherwood MC; Logsdon MN; Horner JW; DePinho RA; Izumo S; Cantley LC
    Mol Cell Biol; 2005 Nov; 25(21):9491-502. PubMed ID: 16227599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras.
    Jimenez C; Hernandez C; Pimentel B; Carrera AC
    J Biol Chem; 2002 Nov; 277(44):41556-62. PubMed ID: 12196526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver.
    Du K; Herzig S; Kulkarni RN; Montminy M
    Science; 2003 Jun; 300(5625):1574-7. PubMed ID: 12791994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation.
    Kruszynska YT; Worrall DS; Ofrecio J; Frias JP; Macaraeg G; Olefsky JM
    J Clin Endocrinol Metab; 2002 Jan; 87(1):226-34. PubMed ID: 11788651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphoinositide 3-kinases p110α and p110β have differential roles in insulin-like growth factor-1-mediated Akt phosphorylation and platelet priming.
    Blair TA; Moore SF; Williams CM; Poole AW; Vanhaesebroeck B; Hers I
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1681-8. PubMed ID: 24903091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide.
    Kurosu H; Maehama T; Okada T; Yamamoto T; Hoshino S; Fukui Y; Ui M; Hazeki O; Katada T
    J Biol Chem; 1997 Sep; 272(39):24252-6. PubMed ID: 9305878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain.
    Antonetti DA; Algenstaedt P; Kahn CR
    Mol Cell Biol; 1996 May; 16(5):2195-203. PubMed ID: 8628286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells.
    Pirola L; Bonnafous S; Johnston AM; Chaussade C; Portis F; Van Obberghen E
    J Biol Chem; 2003 May; 278(18):15641-51. PubMed ID: 12594228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO).
    Jücker M; Südel K; Horn S; Sickel M; Wegner W; Fiedler W; Feldman RA
    Leukemia; 2002 May; 16(5):894-901. PubMed ID: 11986952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance.
    Duan C; Yang H; White MF; Rui L
    Mol Cell Biol; 2004 Sep; 24(17):7435-43. PubMed ID: 15314154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Knockout of PKC alpha enhances insulin signaling through PI3K.
    Leitges M; Plomann M; Standaert ML; Bandyopadhyay G; Sajan MP; Kanoh Y; Farese RV
    Mol Endocrinol; 2002 Apr; 16(4):847-58. PubMed ID: 11923480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance.
    Taniguchi CM; Aleman JO; Ueki K; Luo J; Asano T; Kaneto H; Stephanopoulos G; Cantley LC; Kahn CR
    Mol Cell Biol; 2007 Apr; 27(8):2830-40. PubMed ID: 17283057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new role for the p85-phosphatidylinositol 3-kinase regulatory subunit linking FRAP to p70 S6 kinase activation.
    Gonzalez-Garcia A; Garrido E; Hernandez C; Alvarez B; Jimenez C; Cantrell DA; Pullen N; Carrera AC
    J Biol Chem; 2002 Jan; 277(2):1500-8. PubMed ID: 11684675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distinct and opposing roles for the phosphatidylinositol 3-OH kinase catalytic subunits p110α and p110β in the regulation of insulin secretion from rodent and human beta cells.
    Kolic J; Spigelman AF; Plummer G; Leung E; Hajmrle C; Kin T; Shapiro AM; Manning Fox JE; MacDonald PE
    Diabetologia; 2013 Jun; 56(6):1339-49. PubMed ID: 23568272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Properties of FDA-approved small molecule phosphatidylinositol 3-kinase inhibitors prescribed for the treatment of malignancies.
    Roskoski R
    Pharmacol Res; 2021 Jun; 168():105579. PubMed ID: 33774181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of the splice variants of the p85alpha regulatory subunit of phosphoinositide 3-kinase in muscle and adipose tissue of healthy subjects and type 2 diabetic patients.
    Lefai E; Roques M; Vega N; Laville M; Vidal H
    Biochem J; 2001 Nov; 360(Pt 1):117-26. PubMed ID: 11695998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain.
    Hofmann BT; Jücker M
    Cell Signal; 2012 Oct; 24(10):1950-4. PubMed ID: 22735814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer.
    Luo J; Cantley LC
    Cell Cycle; 2005 Oct; 4(10):1309-12. PubMed ID: 16131837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.